Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children

Condition:   Growth Retardation Intervention:   Drug: PEG-somatropin Sponsor:   GeneScience Pharmaceuticals Co., Ltd. Recruiting - verified September 2017

Source: ClinicalTrials.gov - September 19, 2017 Category: Research Source Type: clinical trials